Virginia has been on a fast-track to legalize since Governor Ralph Northam included cannabis legalization in his budget in December. During his State of the Commonwealth speech this week, Northam reiterated his support for legalization, calling specifically for legalization focused on equity and acknowledging that the criminal justice system “treats different people unfairly.”
“Marijuana is a great example,” Northam said, noting that while white and Black people use cannabis at similar rates, Black people are three and a half times more likely to be charged with a cannabis-related crime, and are almost four times as likely to be convicted. “It’s time,” he said, to “make marijuana legal and end the current system rooted in inequity. We’ve done the research and we can do this the right way, leading with social equity, public health, and public safety.”
Now, Virginia’s legalization plan is already coming together, with the formation of a “Marijuana” subcommittee that is planning to meet twice next week. Details emerged during Friday’s Senate Rehabilitation and Social Services committee meeting.
The subcommittee on Marijuana is scheduled to meet on Tuesday and Wednesday morning to begin discussion of the legislation unveiled by the governor and lawmakers this week. Senator Jeremy McPike will serve as chair. Other members include Senators Ryan McDougle, Scott Surovell, Bryce Reeves, Jennifer Kiggans, Jennifer Boysko, and Lionell Spruill, Sr.
On Friday, Deputy Secretary of Agriculture and Forestry Bradley Copenhaver gave an overview of the legalization proposal. When Northam came out in support of legalization, he established five priorities, which included: social, racial, and economic equity; public health; protections for young people; the requirement to uphold the Virginia Indoor Clean Air Act; and, finally, data collection, which Virginia officials hope positions the state as a model in its approach to legalization.
“This is an area where Virginia has an opportunity to be a real national leader on this issue. According to public health experts that we spoke to, no other state has taken such a comprehensive preemptive approach to collect robust data on all these topics before the legal market opens. So we’re really going to monitor the impact of the policies that we implement,” Copenhaver said during Friday’s meeting.
Zooming in on the timeline, legal sales could start by January 1, 2023, with regulators promulgating rules by July 1, 2022. Expungement would start when the bill takes effect, as soon as July 1, 2021. Home grow of two mature and two immature plants would be allowed per household, and the state is looking to control the density of shops. As Cannabis Wire recently reported, results of a RAND Corporation study showed that the density of licensed cannabis shops was “associated” with young adults consuming cannabis, more frequent use, and intentions to consume, and the density of illicit, or unlicensed, shops was linked to young adults’ “heavy” cannabis consumption.
“Efforts to regulate unlicensed retailers and reduce the density of marijuana retailers may be important factors to be considered when developing strategies to mitigate potential public health harms from expanded legal access to marijuana,” lead author Eric Pedersen said in a release about the study.
Virginia’s Alcoholic Beverage Control Authority would regulate cannabis, and a new cannabis advisory board would “counsel” the board. There will also be a Cannabis Health Advisory Council, and the medical cannabis program will be “as untouched as possible,” but move to ABC during a timeline that works for regulators.
“What we learned from other states is that it’s really a good idea to have all marijuana programs under one umbrella,” Copenhaver said, adding that the licensing program would cover cultivation, manufacturing, retail, wholesale, and testing, with a priority for social equity applicants. ABC could limit the number of licenses that can be allocated.
Copenhaver noted that some other states “have not managed their marijuana market as well as they could,” and he pointed to Oregon, which, he said, ”has seen a lot of problems with supply and demand.” (Read Cannabis Wire’s feature on Oregon’s struggle to regulate cannabis.)
Cannabis products would not be allowed to contain nicotine or alcohol, would contain a universal THC symbol, and would be packaged in opaque materials. Retailers would be required to communicate potential risks of using those products.
Under Northam’s plan, taxes would be collected at point of sale, and products would have a 21% excise tax, plus the state’s existing sales tax, and a 3% local tax, bringing the total taxes levied to roughly, 30%, “which is in line with states such as Colorado and Illinois,” Copenhaver said.
“Our goal is really to generate enough revenue for the program and to cover other revenue goals, but then low enough to capture the illicit market,” Copenhaver said.
Copenhaver described the “keystone” of the bill as equity, adding that after work with the Office of Diversity, Equity, and Inclusion, “we feel like we have set up a really good set of principles in this bill.” Equity provisions include reduced license and application fees, and a new cannabis business and equity support team to help applicants through the process, as well as low-interest loans.
A new Cannabis Equity Reinvestment Fund, which would be overseen by a 20-member board, would receive 30% of cannabis tax revenue, to be used for scholarships, grants for workforce development, mentoring, job training, and reentry programs. These revenues would also contribute to the state’s Indigent Defense Fund, and go toward the Cannabis Equity Loan Fund.
“Thousands have been working on this issue of marijuana legalization for a long time,” Copenhaver said. “This bill didn’t appear out of nowhere. It’s the result, really, of a multi-year effort that has culminated in a piece of legislation that our team feels like we can all be proud of.”
Charlotte’s Web’s CW Labs Announce New Scientific Collaboration Researching Hemp CBD Efficacy
Harvard Medical School’s Dr. Staci Gruber, Ph.D. is lead investigator BOULDER, Colo., Feb. 24, 2021 /PRNewswire/ – (TSX: CWEB) (OTCQX: CWBHF) Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), the market leader in hemp CBD wellness products, today announced a long-term scientific collaboration between McLean Hospital, a Harvard Medical School affiliate, and the Company. […]
Harvard Medical School’s Dr. Staci Gruber, Ph.D. is lead investigator
BOULDER, Colo., Feb. 24, 2021 /PRNewswire/ – (TSX: CWEB) (OTCQX: CWBHF) Charlotte’s Web Holdings, Inc. (“Charlotte’s Web” or the “Company”), the market leader in hemp CBD wellness products, today announced a long-term scientific collaboration between McLean Hospital, a Harvard Medical School affiliate, and the Company. Funding and product support are provided by the CW Labs division of Charlotte’s Web Inc.
Two distinct clinical trials will be overseen by lead researcher/investigator Dr. Staci A. Gruber, Ph. D, Associate Professor of Psychiatry at Harvard Medical School and Director of the MIND program at McLean Hospital in Belmont, Mass. These two studies will investigate the efficacy of a custom-formulated, hemp-derived high-CBD product. Clinical trial results are to be published in 2022. Dr. Gruber is also conducting a number of other studies, including a longitudinal observational study of Veterans who use a Charlotte’s Web product.
Dr. Gruber’s Marijuana Investigations for Neuroscientific Discovery (MIND) Program, established in 2014, is the first of its kind, and is dedicated to studying the long-term impact of cannabis and cannabinoids for medical and adult use which utilizes various clinical and cognitive tools as well as multimodal neuroimaging techniques.
We are honored to be working with Dr. Gruber, Harvard Medical School and McLean Hospital on these important clinical trials. Charlotte’s Web remains dedicated to supporting third-party research on hemp CBD investigated by some of the country’s top scientists.
Tim Orr, President of Charlotte’s Web’s CW Labs divison
For More Information About the MIND Program: https://www.drstacigruber.com/
About the MIND Program:
In 2014 Dr. Staci Gruber launched the Marijuana Investigations for Neuroscientific Discovery (MIND) program at Mclean Hospital, a Harvard Medical School affiliate. The MIND program is the first program of its kind designed to clarify the specific effects of medical cannabis use and is designed to support a wide range of study designs that generate ecologically valid, empirically sound data to close the gap between policy and science. MIND utilizes valid, robust research models and supports numerous projects designed to address the impact of medical cannabis on important variables such as cognition, brain structure and function, mood, conventional medication use, quality of life, pain, sleep, and other health-related measures. Through observational longitudinal investigations, survey studies, and clinical trials of custom-formulated cannabinoid products, MIND aims to examine the unique and synergistic effects of cannabis and its constituents to determine the efficacy of cannabinoids for specific conditions and diseases and to clarify the overall impact of cannabinoid-based treatments on physical and mental health. MIND is poised to improve patients’ overall wellbeing by striving to harness the therapeutic potential while minimizing harms of cannabinoid-based treatment.
About Charlotte’s Web and its CW Labs Division
Charlotte’s Web Labs (“CW Labs”) is the research and development division of Charlotte’s Web, advancing science around hemp-derived phytocannabinoids, terpenes and flavonoid compounds. CW Labs is headquartered at the Hauptmann Woodward Research Institute on the campus of the University at Buffalo’s Jacobs School of Medicine and The Center for Integrated Global Biomedical Sciences, and is part of the State University of New York (SUNY) network of 64 national and international research and medical institutions.
About Charlotte’s Web Holdings, Inc.
Charlotte’s Web Holdings, Inc., a Certified B Corporation headquartered in Boulder, Colorado, is the market leader in the production and distribution of innovative hemp-derived cannabidiol (“CBD”) wellness products under a family of brands which includes Charlotte’s Web™, CBD Medic™, CBD Clinic™, and Harmony Hemp. The Company’s premium quality products start with proprietary hemp genetics that are 100-percent American farm grown and manufactured into whole-plant hemp extracts containing a full spectrum of naturally occurring phytocannabinoids including CBD, CBC, CBG, terpenes, flavonoids and other beneficial hemp compounds. Charlotte’s Web product categories include CBD oil tinctures (liquid products), CBD gummies (sleep, stress, inflammation recovery), CBD capsules,CBD topical creams and lotions, as well as CBD pet products for dogs. Charlotte’s Web is the number one CBD brand in the USA and distributed through more than 22,000 retail locations, select distributors and online through the Company’s website at www.CharlottesWeb.com.
Charlotte’s Web was founded by the Stanley Brothers with a mission to unleash the healing powers of botanicals through compassion and science, benefiting the planet and all who live upon it. Charlotte’s Web is a socially and environmentally conscious company and is committed to using business as a force for good and a catalyst for innovation. The Company weighs sound business decisions with consideration for how its efforts affect employees, customers, the environment, and diverse communities. The rate the Company pays for agricultural products reflects a fair and sustainable rate driving higher quality yield, encouraging regenerative farming practices, and supporting U.S. farming communities. Management believes that its socially oriented and environmentally responsible actions have a positive impact on its customers, suppliers, employees, and stakeholders. Charlotte’s Web donates a portion of its pre-tax earnings to charitable organizations.
Subscribe to Charlotte’s Web investor news.
Is cbd oil worth it’s price or should I stick to flower?
Tldr- bud or bottle?
So, I have been smoking high quality outdoor/greenhouse CBD/CBG from Beleafer. Now, my problem is, I dont really feel effects anymore, like, I use my cbd flower to mix with normal high potency weed and it works great, I feel less paranoia, thats all well, but as I say, if I smoke cbd alone its really like im doing something for nothing, this could be because I only get ounces from Beleafer as they last me months, but I probably have a tolerance with each strain by the time I finish it.
My issue is this. I need relief badly(psychological and physical issues), and when I used a high quality cbd oil, it helped, at low 5% dosage, but it was a pretty penny.
When I look at the cbd I want to get now its 129€ for 40% or I can get 2x 20% for the same price. They are 10ml bottles.
HOWEVER, I can get an ounce of indoor cbd for a similar slightly less price, only issue is shipping times, AND – IS SHIPPING OF CBD FLOWER STILL POSSIBLE OR TOTALLY STOPPED? This is probably my only issue now thinking about it.
I digress, basically I can get good strong cbd to smoke for months, or I can get a bottle of oil that could last a month depending if it works and if I stick to dosages instead of just start doing drops all day.
I enjoy cbd and it does work, I just dont know if I have a high tolerance now and it means I have to only fork out on high potency stuff.
Oh, the point of this post is that with smoking cbd, I cant say I feel any health benefits like pain relief etc, however when I used oil I think it definitely helped in more ways than just one (relaxed after a bong)
What would you do in this case? Bud or bottle?
Oh im in France so this makes it difficult with certain brands that dont ship intl.
Florida Bill Aims to Legalize Medical Magic Mushrooms
Delta 8: Shipping Vape Ban Goes Into Effect Soon – What Does It Means?
Nanocrystallization of a Ti40 cladding layer by ultrasonic impact to improve burn resistance
Local Turkish DKP grade scrap prices remain stable
Explained: How CBD Oil is Different Than CBD Capsule?
Wear behavior of nanostructured carbo-austempered cast steels under rolling-sliding conditions
Bermuda Prepares To Lock Horns With United Kingdom Over Adult Use Cannabis
Chemical attack and corrosion resistance of concrete prepared with electrolyzed water
CBD and Inflammation
Growth kinetics of the FeB/Fe2B boride layer on the surface of 4Cr5MoSiV1 steel: experiments and modelling
Competitive mechanisms occurring during quenching and partitioning of three silicon variants of 0.4 wt.% carbon steels
Unnamed Company Tried to Buy Aphria While It Was Negotiating Tilray Merger
Where To Buy CBD in Fort Worth
Efficacy of CBD Edibles
Influence of heavy metal oxides to the mechanical and radiation shielding properties of borate and silica glass system
Questions about taking CBD oil for anxiety
Activated carbon electrode with promising specific capacitance based on potassium bromide redox additive electrolyte for supercapacitor application
Is CBD isolate effective for anxiety?
Kanabo looks fully valued
Sir Keir Starmer rules out relaxing cannabis laws in the UK
High Times covers Humboldt's 'bold' industrial hemp ban, county official answers a couple questions
CBD Has Been Getting Me High
Hemp NZ appoints new board chair
drug test soon help
5 best CBD gummies you can buy in the UK in 2021
Investigation of microstructural attributes of steel surfaces through magneto-optical Kerr effect
Ex-China plate prices up sharply following surge in local prices
Heartland1 week ago
Biochemical aspects of seeds from Cannabis sativa L. plants grown in a mountain environment
Heartland1 week ago
GSCG Launches New Interactive Website: Illinois Hemp Summit Participation
Heartland1 week ago
Ag. secy. seeks grants to boost hemp sales
Heartland1 week ago
Humboldt County, California, permanently bans hemp cultivation
Heartland1 week ago
CBD Oil Recommendations for Autism and ADHD (UK)?
News1 week ago
Fiore Cannabis Announces Sale of Surplus Cannabis Licence to Fund Expansion of Apex Cultivation Facility
News1 week ago
TILT Holdings Provides Preliminary Fourth Quarter Results, Operational Highlights and 2021 Outlook
Uncategorized1 week ago
How to Apply for a Massachusetts Cannabis License